Sponsored
Article Tools

Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe

Published: December 19, 2012; 09:00 · (Vindobona)

Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe

Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe / Picture: © Vindobona Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.

Company Information

Wien (euro adhoc) - Vienna (Austria), December 19, 2012 - Intercell AG (VSE;
"ICLL") today announced that the CHMP of the European Medicines Agency (EMA) has
come to a positive opinion on the Marketing…

This article includes a total of 599 words.

or Log In